# US 2008/0188555 A1 · Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188555 A1
- Document ID: US20080188555A1
- Status: Published application
- Kind: A1
- Application number: 12/026,861
- Filed: 2008-02-06
- Published: 2008-08-07
- Earliest claimed: 2007-02-06
- Assignees: Medical Research Council
- Inventors: Jonathan Joseph Powell; Sylvaine Francoise Bruggraber; Nuno Jorge Rodrigues Faria; Dora Isabel Amaral Pereira
- Web page: https://patentgrep.com/patent/US20080188555A1

## CPC

- C07F 15/025: {without a metal-carbon linkage}
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 7/06: Antianaemics
- A61P 39/00: General protective or antinoxious agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07G 99/00: Subject matter not provided for in other groups of this subclass
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07G: COMPOUNDS OF UNKNOWN CONSTITUTION (sulfonated fats, oils or waxes of undetermined constitution C07C309/62)

## Abstract

Ligand-modified poly oxo-hydroxy metal ion materials and their uses are disclosed, in particular for nutritional, medical, cosmetic or biologically related applications for example for the treatment of a deficiency related to a component of the material or for the removal of an endogenous substance capable of binding to the material. The present invention further relates to processes for preparing the materials and optimising their physico-chemical properties and their medical uses.

## Claims

### Claim 1

A process for producing a solid ligand-modified poly oxo-hydroxy metal ion material (MxLy(OH)n), wherein M represents one or more metal ions, L represents one or more ligands and OH represents oxo or hydroxy groups and n represents a polymeric structure, and wherein the gross solid ligand-modified poly oxo-hydroxy metal ion material has one or more reproducible physico-chemical properties and displays M-L bonding for at least one ligand that can be detected by physical analytical techniques,
the process comprising:
(a) mixing the metal ions M and the ligands L at a first pH(A) at which the components are soluble;
(b) changing the pH(A) to a second pH(B) to cause a solid precipitate of the solid ligand-modified poly oxo-hydroxy metal ion material to be formed; and
(c) separating, and optionally drying, the solid ligand-modified poly oxo-hydroxy metal ion material produced in step (b).

### Claim 2 (depends on 1)

The process of claim 1, further comprising formulating the solid ligand-modified poly oxo-hydroxy metal ion material in a composition for administration to a subject.

### Claim 3 (depends on 2)

The process of claim 2, wherein the composition is for use as a nutritional, medical, cosmetic or other biologically applicable composition.

### Claim 4 (depends on 1, 2, 3)

The process of any one of claims 1 to 3, wherein the composition is for delivery of the metal ion or the ligand to a subject.

### Claim 5 (depends on 1, 2, 3)

The process of any one of claims 1 to 3, wherein the composition is for sequestering or inhibiting a component present in the subject using the solid ligand-modified poly oxo-hydroxy metal ion material.

### Claim 6

The process of any one of the preceding claims, wherein the pH(A) is above a pH at which hydroxy polymerisation of the corresponding metal hydroxide commences.

### Claim 7

The process of any one of the preceding claims, wherein the pH is changed from pH(A) to pH(B) by the addition of alkali.

### Claim 8 (depends on 7)

The process of claim 7, wherein the alkali is added as a solution of sodium hydroxide, potassium hydroxide or sodium bicarbonate to increase the concentration of OH in the mixture of step (b).

### Claim 9 (depends on 7, 8)

The process of claim 7 or claim 8, wherein pH(A) is less than or equal to pH 2 and pH(B) is greater than or equal to pH 2.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6)

The process of any one of claims 1 to 6, wherein the pH is changed from pH(A) to pH(B) by the addition of acid.

### Claim 11 (depends on 10)

The process of claim 10, wherein the acid is added as a mineral acid or an organic acid to decrease the concentration of OH in the mixture of step (b).

### Claim 12 (depends on 10, 11)

The process of claim 10 or claim 11, wherein pH(B) is less than or equal to pH 2 and pH(A) is greater than or equal to pH 2.

### Claim 13

The process of any one of the preceding claims, wherein the one or more reproducible physico-chemical properties are selected from dissolution (rate, pH dependence and pM dependence), adsorption and absorption characteristics, reactivity-inertness, melting point, temperature resistance, particle size, magnetism, electrical properties, density, light absorbing/reflecting properties, hardness-softness, colour and encapsulation properties.

### Claim 14 (depends on 13)

The process of claim 13, wherein the reproducible physico-chemical property is reproducible within a limit of ±5%, and more preferably within a limit of ±2%.

### Claim 15

The process of any one of the preceding claims, wherein the polymeric structure in which the M, L and oxo or hydroxy groups are distributed within the solid phase structure is such that the substitution of the oxo or hydroxy groups by the one or more ligands is substantially random.

### Claim 16

The process of any one of the preceding claims, wherein the metal ion (M) is a Group 2, 3 or 5 metal ion, a transition metal ion, a heavy metal ion or a lanthanide ion.

### Claim 17 (depends on 16)

The process of claim 16, wherein the metal ion (M) is selected from Ag2+, Al3+, Au3+, Be2+, Ca2+, Co2+, Cr3+, Cu2+, Eu3+, Fe3+, Mg2+, Mn2+, Ni2+, Sr2+, V5+, Zn2+ or Zr2+.

### Claim 18 (depends on 16, 17)

The process of claim 16 or claim 17, wherein the metal ion (M) is Fe3+.

### Claim 19

The process of any one of the preceding claims, wherein the ligand species (L) is selected from a carboxylic acid such as glutaric acid, tartaric acid, malic acid, succinic acid and citric acid, a sugar such as maltol and ethyl maltol, an anion with ligand properties such as bicarbonate, sulphate and phosphate, a mineral ligand such as silicate, molybdate and selenate, an amino acid such as tryptophan, glutamine or histidine or a nutrient-based ligand such as folate, ascorbate or niacin.

### Claim 20

The process of any one of the preceding claims, wherein the ligand has buffering properties or a buffer is present in a medium for carrying out the process.

### Claim 21 (depends on 20)

The process of claim 20, wherein the buffer is selected from an inorganic buffer, such as borate, silicate or bicarbonate, or an organic buffer such as MOPS, HEPES, PIPES or TRIS, or a buffer selected from adipic acid, pimelic acid, tryptophan or hydroxymethylcellulose.

### Claim 22

The process of any one of the preceding claims, wherein the composition is for use an iron supplement.

### Claim 23

A process for producing a solid ligand-modified poly oxo-hydroxy metal ion material and optimising a desired physico-chemical property of the material to adapt it for a nutritional, medical, cosmetic or biologically related application, wherein the solid ligand-modified poly oxo-hydroxy metal ion material is represented by the formula (MxLy(OH)n), wherein M represent one or more metal ions, L represents one or more ligands and OH represents oxo or hydroxy groups and n represents a polymeric structure, wherein the gross solid ligand-modified poly oxo-hydroxy metal ion material has one or more reproducible physico-chemical properties and displays M-L bonding for at least one ligand that can be detected by physical analytical techniques,
the process comprising:
(a) mixing the metal ion(s) M and the ligand(s) L in a reaction medium at a first pH(A) at which the components are soluble;
(b) changing the pH(A) to a second pH(B) to cause a solid precipitate of the ligand-modified poly oxo-hydroxy metal ion material to be formed;
(c) separating, and optionally drying, the solid ligand-modified poly oxo-hydroxy metal ion material produced in step (b).
(d) testing the desired physico-chemical characteristic(s) of the precipitated solid ligand-modified poly oxo-hydroxy metal ion material; and
(e) repeating steps (a) to (d) as required by varying one or more of:
(i) the identity or concentration of the metal ion(s) (M) and/or the ligand(s) (L) supplied in step (a); and/or
(ii) the ratio of metal ion(s) (M) to ligand(s) (L) supplied in (a); and/or
(iii) pH(A); and/or
(iv) pH(B); and/or
(v) the rate of change from pH(A) to pH(B); and/or
(vi) the presence or concentration of a buffer;
thereby to produce a solid ligand-modified poly oxo-hydroxy metal ion material having the desired physico-chemical property.

### Claim 24 (depends on 23)

The process of claim 23, which further comprises varying a physical or chemical reaction condition used in the process for making the solid ligand-modified poly oxo-hydroxy metal ion material.

### Claim 25 (depends on 24)

The process of claim 24, wherein the physical or chemical reaction condition is selected from the temperature of the reaction, the rate of pH change or the use or the conditions used to mix the reactants.

### Claim 26 (depends on 23, 24, 25)

The process of any one of claims 23 to 25, wherein the first pH(A) is a pH below the pH at which hydroxy polymerisation of the corresponding metal hydroxide commences.

### Claim 27 (depends on 26)

The process of claim 26, wherein pH(A) is less than or equal to pH 2 and pH(B) is greater than or equal to pH 2.

### Claim 28 (depends on 23, 24, 25, 26, 27)

The process of any one of claims 23 to 27, wherein the pH is changed from pH(A) to pH(B) by the addition of acid.

### Claim 29 (depends on 28)

The process of claim 28, wherein the acid is added as a mineral acid or an organic acid to decrease the concentration of OH in the mixture of step (b).

### Claim 30 (depends on 23, 24, 25)

The process of any one of claims 23 to 25, wherein pH(B) is less than or equal to pH 2 and pH(A) is greater than or equal to pH 2.

### Claim 31 (depends on 23, 24, 25, 26, 27, 28, 29, 30)

The process of any one of claims 23 to 30, wherein the pH change from pH(A) to pH(B) occurs in a 24 hour period or less, more preferably within an hour period and most preferably within 20 minutes.

### Claim 32 (depends on 23, 24, 25, 26, 27, 28, 29, 30)

The process of any one of claims 23 to 30, wherein the concentrations of total metal ions (M) and total ligand (L) are greater than 10−6 molar, and more preferably are greater than 10−3 molar.

### Claim 33 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

The process of any one of claims 23 to 32, wherein the reaction medium is an aqueous solution.

### Claim 34 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

The process of any one of claims 23 to 33, wherein buffer stabilises the pH range of hydroxy polymerisation.

### Claim 35 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The process of any one of claims 23 to 34, wherein the buffer is selected from an inorganic buffer, such as borate, silicate or bicarbonate, or an organic buffer such as MOPS, HEPES, PIPES or TRIS, or a buffer selected from adipic acid, pimelic acid, tryptophan or hydroxymethylcellulose.

### Claim 36 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The process of any one of claims 23 to 35, wherein the buffer concentrations are less than 500 mM, preferably less than 200 mM and most preferably less than 100 mM.

### Claim 37 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

The process of any one of claims 23 to 36, wherein the temperature of the reaction is between 0 and 100° C., and more preferably between room temperature (20-30° C.) and 100° C.

### Claim 38 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

The process of any one of claims 23 to 36, wherein the ionic strength of the reaction medium is varied by addition of electrolyte.

### Claim 39 (depends on 25)

The process of claim 25, wherein the components are mixed in step (a) to for a homogeneous solution.

### Claim 40 (depends on 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

A process for making a solid ligand-modified poly oxo-hydroxy metal ion material for administration to a subject, the process comprising having optimised a solid ligand-modified poly oxo-hydroxy metal ion material according to the process of any one of claims 23 to 39 as disclosed herein, the further step of manufacturing the solid ligand-modified poly oxo-hydroxy metal ion material in bulk and/or formulating it in a composition.

### Claim 41

A composition for administration to a subject comprising a solid ligand-modified poly oxo-hydroxy metal ion material represented by the formula (MxLy(OH)n), wherein M represent one or more metal ions, L represents one or more ligands and OH represents oxo or hydroxy groups, wherein the composition is as obtainable by the process of any one of the preceding claims.

### Claim 42 (depends on 41)

The composition of claim 41, wherein delivery of the metal ion provides therapeutic benefit to the subject.

### Claim 43 (depends on 41)

The composition of claim 41, wherein the material is for use in the therapeutic removal or inhibition of an endogenous substance present in the subject that is capable of binding to the solid ligand-modified poly oxo-hydroxy metal ion material.

### Claim 44

A ferric iron composition for administration to a subject which comprises a solid ligand-modified poly oxo-hydroxy metal ion material represented by the formula (MxLy(OH)n), wherein M represents one or more metal ions that comprise Fe3+ ions, L represents one or more ligands and OH represents oxo or hydroxy groups and n represents a polymeric structure in which the ligands L are substantially randomly substituted for the oxo or hydroxy groups, the solid polyhydroxy-metal ion-ligand material having one or more reproducible physico-chemical properties and demonstrable M-L bonding using physical analysis.

### Claim 45 (depends on 44)

The ferric iron composition of claim 44, wherein M is Fe3+ ions.

### Claim 46 (depends on 44, 45)

The ferric iron composition of claim 44 or claim 45, wherein the substantially randomly solid phase structure of the material produced by substitution of hydroxy or oxo groups by the ligand L is determinable by an X-ray diffraction pattern having no identifiable peaks for L or MO/MOH.

### Claim 47 (depends on 44, 45, 46)

The ferric iron composition of any one of claims 44 to 46, wherein the substantially randomly solid phase structure of the material produced by substitution of hydroxy or oxo groups by the ligand L is an increase in the amorphousness of the structure of the material as determinable by high resolution transmission electron microscopy.

### Claim 48 (depends on 44, 45, 46, 47)

The ferric iron composition of any one of claims 44 to 47, wherein the reproducible physico-chemical property is selected from one or more of a dissolution profile, an adsorption profile or a reproducible elemental ratio.

### Claim 49 (depends on 48)

The ferric iron composition of claim 48, wherein the reproducible elemental ratio is reproducible within a limit of ±5%, and more preferably within a limit of ±2%.

### Claim 50 (depends on 44, 45, 46, 47, 48, 49)

The ferric iron composition of any one of claims 44 to 49, wherein the infrared spectra further comprises one or more peaks for the bonds between M-O, O—H, and L alone.

### Claim 51 (depends on 47, 48, 49, 50)

The ferric iron composition of any one of claims 47 to 50, wherein the ligand L comprises tartarate or malate.

### Claim 52 (depends on 51)

The ferric iron composition of claim 51, wherein the ligand L comprises tartarate and adipate.

### Claim 53 (depends on 51)

The ferric iron composition of claim 51, wherein the ligand L comprises malate and bicarbonate.

### Claim 54 (depends on 47, 48, 49, 50, 51, 52, 53)

The ferric iron composition of any one of claims 47 to 53, wherein the ratio M:L is between about 2:1 and 5:1.

### Claim 55 (depends on 47, 48, 49, 50, 51, 52, 53, 54)

The ferric ion composition of any one of claims 47 to 54 which is FeT-3:1-Ad20 and FeM-4:1-Bic20.

### Claim 56 (depends on 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55)

The ferric iron composition of any one of claims 44 to 55, wherein the composition is a supplement, a fortificant or a food additive.

### Claim 57 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55)

Use of a composition of a solid ligand-modified poly oxo-hydroxy metal ion material (MxLy(OH)n) as obtainable by the process of any one of claims 1 to 43 or as defined in any one of claims 44 to 55 for the preparation of a medicament for therapeutic delivery of the metal ion to the subject.
